These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25537728)

  • 1. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
    Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
    J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
    Inoue K; Fry EA
    Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.
    Tschan MP; Federzoni EA; Haimovici A; Britschgi C; Moser BA; Jin J; Reddy VA; Sheeter DA; Fischer KM; Sun P; Torbett BE
    Biochim Biophys Acta; 2015 Sep; 1849(9):1198-208. PubMed ID: 26187004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
    Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
    Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.
    Fry EA; Taneja P; Maglic D; Zhu S; Sui G; Inoue K
    PLoS One; 2013; 8(10):e77870. PubMed ID: 24205004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
    Zhu S; Mott RT; Fry EA; Taneja P; Kulik G; Sui G; Inoue K
    Am J Pathol; 2013 Oct; 183(4):1339-1350. PubMed ID: 23938323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
    Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
    J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
    Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin sensitivity in breast cancer cells is associated with particular DMTF1 splice variant expression.
    Niklaus NJ; Humbert M; Tschan MP
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2800-2806. PubMed ID: 30100063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
    Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
    Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
    Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
    Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dmp1 and tumor suppression.
    Inoue K; Mallakin A; Frazier DP
    Oncogene; 2007 Jun; 26(30):4329-35. PubMed ID: 17237816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.
    Fifield BA; Vusich J; Haberfellner E; Andrechek ER; Porter LA
    Breast Cancer Res; 2024 Jun; 26(1):106. PubMed ID: 38943151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.
    Tanaka N; Yoshida H; Suzuki Y; Harigaya K
    Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.
    Sugiyama T; Frazier DP; Taneja P; Kendig RD; Morgan RL; Matise LA; Lagedrost SJ; Inoue K
    Clin Med Oncol; 2008; 2():209-19. PubMed ID: 21892281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.